Monocarboxylate transporter-1 (MCT1) protein expression in head and neck cancer affects clinical outcome
Abstract Treatment of locally advanced, unresectable head and neck squamous cell carcinoma (HNSCC) often yields only modest results with radiochemotherapy (RCT) as standard of care. Prognostic features related to outcome upon RCT might be highly valuable to improve treatment. Monocarboxylate transpo...
Main Authors: | Martin Leu, J. Kitz, Y. Pilavakis, S. Hakroush, H. A. Wolff, M. Canis, S. Rieken, M. A. Schirmer |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-84019-w |
Similar Items
-
Monocarboxylate Transporter 1 (MCT1) in Liver Pathology
by: Marek Droździk, et al.
Published: (2020-02-01) -
Role and regulation of the human colonic monocarboxylate transporter, MCT1
by: Cuff, Mark Anthony
Published: (2001) -
Regulation of the exercise-induced expression of the monocarboxylate transporters MCT1 and MCT4 in skeletal muscle
by: Taku Hamada, et al.
Published: (2013-04-01) -
Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
by: Theresa Porst, et al.
Published: (2021-04-01) -
The Hepatic Monocarboxylate Transporter 1 (MCT1) Contributes to the Regulation of Food Anticipation in Mice
by: Tomaz Martini, et al.
Published: (2021-04-01)